Диабзид М 500 мг+80 мг таблетки

국가: 키르기스스탄

언어: 러시아어

출처: Правительства Кыргызской Республики (Департамент лекарственного обеспечения и медицинской техники)

유효 성분:

метформина гидрохлорид + гликлазид

제공처:

Medeor Life Care LLP (Medeor Life Care LLP)

ATC 코드:

A10BD02

INN (국제 이름):

Metformin hydrochloride + gliclazide

복용량:

500 мг+80 мг

약제 형태:

таблетки

패키지 단위:

№30

처방전 유형:

по рецепту

Manufactured by:

Rathamani Healthcare Pvt. Ltd. (Индия)

제품 요약:

ПЖВЛС: нет

승인 날짜:

2017-09-22

제품 특성 요약

YTBEPXIAIO
If
epnrrfi
3aMecrnTeJrb
Arrper$opa
Ieuapra
ooec[erleHLIg
Mun
IJil
I,rHCTpyKIIrIfl
nOMEAT,ITII4HCKOMyIIPI,IMEHEHI,IIO
CPEICTBA
AI,TAE3I4I-M
(Mersoprvru'
rrrApoxJroprAa
500
nrr
frururcragnA
g0
nar
ra6nerrcn)
PerncrpaqlroHnrrfi
HoMep
Topronoe
Ha3BaHrre:
Aualsul-M
MeN4ynapoAHoe
Herrare'ToBaHrroe
HarrMerroBa'r{e:
Her
JlercapcrneHHaq
Sopua
Ta6lerxz
Cocras
Kaxlas
ra6nerrca
coAeplKr4
T
Arcmueuarc
6eu4ecm6a:
Mer(foprrazHa
ruApoxnopra4
Bp
500
rrar
fruKnagua
BP
80
rrar
BcnouozamerbHbre
eeu4ecmna:
MI4KpoKpr4crann[qecKar
qenJr]oJro3a,
r(yKypyanrrfi
KpocKapMeno3a
Harpnfr',
noBvlrou
(PVPK
30),
ronnouAnuft
6essoAHuft
Ar.roKcr.r.u
MarHr.rr
cTeapaT.
17r.
TIHOIO
KprxMrrJr,
KpeMHrIt,
Onncaune
Belrre
xancynoo6ptBHble'
ABotKoBbIrIyKJrbre
ra6rerxz
c ttu:rtueitprunoMa
na
o4nofi
cropoHe
H
poBHbre
Ha
4pyroft
cropoHe.
OapuarcorepaneBTrrqecKar
rpynfla
Korrl6nHaqun6nryauuAoB
I{
[po]r3BoAHnx
cynrQoHr4rMorreBr4Hu
Mer$opMrrH
B
rou6uHarlrz
c
[por.r3Bo,qHrnuu
cylr$oHrdJrMoqeBr.rHbr
Koa
ATX:
A10BD02
Oapnrarco.lor[qecKrre
cnofi
crsa
(DapnaxoduHsJnuKa
/
fnrarraszA
cHllxaer
ypoBeHb
rilroKo3bl
B KpoBr.r
nyreu
KoppeKrlr.ru
rax
gefterruaur
ceKperlr4s
HIJcynu]Ha
a nepIESepHqecKat
pe3l4creHTHocrb
K
r,rHcyJrr.rHy.
3ro
uporacxoAr{T
no
3aKpbrrrr.r
K*
KaHUIJIOB
s
6era
KJIeroK
B rloAxenyAoqnofi
xeJre3e.
Bnocne4crB4kr,
Caz*
KaHaJr
orKpbrBaer
BeIyl{I4ft
K
yBenI'IrreHI{Io
BHyrpl{rrero.Iurrft
rzurrqufi
pr
r{HAyKrlraro
ssrcso6o)KAeHr.rs
r4*cy'ruHa.
fnuxla-:Ia4
TaKXe
yBerI4tII'IBaer
qyBcrBllTenbuocrb
6era-rlerox
K
rJrroKo3e.
frzxnasu.u
BoccraHaBJII4Baer
qyBcrBvreJlbHocrb
r
repu$epnqecKoMy
prncyrrkrHy,
TaKoe
KaK
yMe'brueHrre
npoAyKrll{u
rJIIoKo3bI
neqeHblo
u rroBbrrrreHrre
KJrr.rpeHca
rnloKo3br.
On zueer
aHTr,r-a,qre3r,rBHyro
aKTI'IBHocrr
rpou6oql{ToB
pI
cHllxaer
ypoBeHb
cno6o4Hrrx
paAr4Ki}JroB,
TaKr.rM
o6pasorra
rlpeAorBparllas
cocyl.rrcrble
ocJloxHeHuq.
fnurna-:z4,
KaK
coo6qa-nocb,
cHr4xaer
ypoBeHb
XONECTEPZHA
B
IIJIA3ME
I{
TPIITJIIZqEPI,IAOB
NOCJIE
IIOBTOPHO|O
BBEAEHI4fl.
MerSopnaan
4efictnyer
KaK
aHTllruneprJrr.rKerrlraqecr[fi
afeHT
nyr€u ynrrureHrnr